Biglycan is a small leucine-rich proteoglycan (SLRP) of the extracellular matrix (ECM) encoded by the BGN gene on the X chromosome. According to NCBI Gene records, human biglycan is a secreted matrix component involved in collagen fibrillogenesis, bone growth, muscle development, and innate immune signaling via pattern-recognition receptors such as TLR2 and TLR4 GenBank+1. These properties make Biglycan ELISA a valuable research tool for quantifying biglycan protein levels in serum, plasma, cell culture supernatant, tissue extracts and other biological samples in ECM biology, inflammation, and biomarker discovery studies.

This article provides a technical, SEO-optimized description of Biglycan ELISA, including molecular background, assay principle, sample handling, analytical performance and optimization strategies, with emphasis on research-use-only applications.

Molecular Background of Biglycan (BGN)

The human BGN gene is documented in detail in the NCBI Gene: BGN (Homo sapiens) entry, which describes biglycan as an ECM proteoglycan with a core protein decorated by chondroitin sulfate or dermatan sulfate chains GenBank. Orthologous entries exist for mouse Bgn, rat Bgn and other species, facilitating translational comparisons in preclinical models GenBank+1.

Biglycan belongs to the small leucine-rich proteoglycan family, extensively reviewed in the context of ECM biology and the “matrisome” in resources such as the ECM overview from the MIT extracellular matrix guide and the Virginia Tech “Extracellular Matrix” cell biology textbook dspace.mit.edu+1. These references highlight proteoglycans as core ECM structural and signaling elements.

Detailed structural descriptions of proteoglycans and glycosaminoglycans (GAGs) are available from university sources such as the RPI “Proteoglycan sequence” document, the Caltech “glycosaminoglycan code” review and a recent overview of proteoglycans in mechanobiology from UTHealth/TMC Digital Commons dspace.rpi.edu+2HSIEH-WILSON LAB+2. These resources explain how the bottle-brush architecture of proteoglycans, including biglycan, influences hydration, tissue mechanics and cell signaling.

Comprehensive reviews, such as “Biglycan: a multivalent proteoglycan providing structure and signals” in the Journal of Histochemistry & Cytochemistry and related articles accessible via PubMed and PMC, discuss biglycan’s dual structural and signaling functions in musculoskeletal tissues and immunity PubMed+1. Additional NIH-hosted articles describe biglycan as a danger-associated molecular pattern (DAMP) that engages TLR2/4 and promotes sterile inflammation, as summarized in “The matrix component biglycan is proinflammatory and signals through TLR4 and TLR2” PMC and in broader reviews on proteoglycan signaling such as “Biological interplay between proteoglycans and their receptors” PMC.

These curated .gov and .edu resources provide the molecular and functional context that underpins the development of Biglycan ELISA assays.

Principle of Biglycan ELISA

Biglycan ELISA is typically configured as a quantitative sandwich ELISA. The general ELISA principle is extensively described in academic resources, for example:

• The Harvard DASH paper on microfluidic paper-based ELISA dash.harvard.edu

• The University of Michigan microfluidic ELISA protocol fanlab.bme.umich.edu

• The ELISA laser platform for ultrasensitive quantification from the same group at UMich fanlab.bme.umich.edu

In a Biglycan ELISA kit, the typical steps are:

1. Coated capture antibody specific for human biglycan is immobilized on a microplate.

2. Sample or biglycan standards are added; biglycan binds to the capture antibody.

3. A biotinylated or enzyme-conjugated detection antibody recognizing a different epitope binds the captured biglycan, forming a capture–antigen–detection “sandwich”.

4. An enzyme conjugate (e.g., streptavidin-HRP) is added if required by the format.

5. A chromogenic substrate (e.g., TMB) is converted to a colored product; absorbance is measured at 450 nm (with reference at 620–630 nm).

6. A standard curve generated from known concentrations of recombinant biglycan allows quantification in unknown samples by fitting a four-parameter logistic (4-PL) or similar model.

Advanced immunoassay platforms, such as the single-molecule colocalization ELISA described by the Soh Lab at Stanford (PDF hosted on stanford.edu), demonstrate how sophisticated detection strategies can push ELISA sensitivity while still relying on the same fundamental immunochemical principles Soh Lab+1.

Sample Types and Pre-analytical Considerations

Biglycan ELISA kits are generally validated for serum, plasma (EDTA, heparin, citrate), cell culture supernatants, and tissue or ECM extracts. Pre-analytical handling should follow good laboratory practices derived from generic immunoassay method development, such as those described in the dried blood spot ELISA validation study from the University of Michigan Deep Blue repository Deep Blue.

Key points include:

• Avoid repeated freeze–thaw cycles that can fragment proteoglycans or cleave GAG chains.

• Use protease inhibitors during tissue or ECM extraction when studying biglycan protein levels or neo-epitopes.

• Standardize dilution factors to bring biglycan concentration into the dynamic range of the ELISA.

• Record collection conditions (time, anticoagulant, storage) to minimize matrix-related variability.

Because biglycan is an ECM molecule, its representation in biological fluids may depend on shedding, secretion, degradation and complex formation with collagen or other matrix components, as discussed in ECM reviews from Monash University cardiovascular ECM research and matrisome analyses hosted at MIT research.monash.edu+1. For this reason, researchers often evaluate more than one sample matrix (e.g., serum vs. conditioned medium) during assay validation.

Calibration Curve and Analytical Performance

For a high-quality Biglycan ELISA kit, key analytical parameters include:

• Sensitivity (limit of detection, LOD) in the low pg/mL to low ng/mL range

• Dynamic range typically spanning 2–3 orders of magnitude

• Intra-assay and inter-assay CV usually <10–15%

• Spike-and-recovery within ~80–120% in multiple matrices

• Parallelism between endogenous samples and recombinant standard curve

Quantitative ELISA modeling frequently uses Langmuir-type isotherms or logistic models. A Stanford-hosted immunoassay methods paper points out that classical ELISA data are often fit using two parameters (KD and Bmax) or 4-PL logistic equations to describe binding and saturation behavior in calibration curves Soh Lab.

During Biglycan ELISA method development, researchers are encouraged to follow general immunoassay optimization strategies found in academic references such as:

• Microfluidic paper-based ELISA design from Harvard University dash.harvard.edu

• Rapid “instant ELISA” biosensor development hosted at Stanford University Soh Lab

These documents provide generalizable concepts like blocking optimization, surface chemistry, incubation kinetics, and background reduction, which can be translated directly to Biglycan ELISA optimization.

Research Applications of Biglycan ELISA

Because biglycan is a central ECM proteoglycan, Biglycan ELISA is widely applicable in preclinical research fields such as:

1. Musculoskeletal biology and bone remodeling

   • Reviews on biglycan’s structure-function in bone and cartilage from PubMed/NIH summarize evidence that biglycan contributes to bone mass, osteoblast and osteocyte function, and age-related ECM changes PubMed.

   • Mouse models with biglycan deletion show altered bone mineralization and growth, described in mouse Bgn NCBI Gene GenBank. Biglycan ELISA can quantify circulating or tissue-derived biglycan in such models.

2. Cardiovascular and connective tissue research

   • ECM composition in the cardiovascular system is discussed in detail in the Monash cardiovascular ECM review, which highlights proteoglycans in vascular remodeling and stiffness research.monash.edu.

   • Biglycan levels measured by ELISA in experimental models may correlate with ECM remodeling, fibrosis, or vascular calcification in basic research (without implying any diagnostic claim).

3. Inflammation and innate immunity

   • Biglycan acts as a DAMP and engages TLR2/4, as shown in an NIH-hosted article on the pro-inflammatory role of biglycan PMC.

   • Quantitative Biglycan ELISA in cell culture supernatants or animal plasma enables researchers to monitor biglycan release during sterile inflammation and to evaluate interventions that modulate ECM-derived signaling.

4. Oncology and tumor microenvironment

   • A research article on the extracellular SLRP biglycan in gastric cancer indicates that biglycan expression modulates cell survival, migration and angiogenic features in cancer models PMC.

   • In oncology research, Biglycan ELISA can be used to study ECM remodeling, tumor–stroma interaction and cancer-associated fibroblast activity at the protein level, strictly as a research biomarker.

5. Neuromuscular and synaptic biology

   • Studies such as “The Small Leucine-Rich Proteoglycan Biglycan Binds to α-Dystroglycan” describe biglycan localization in muscle and neuromuscular junctions PMC.

   • Biglycan ELISA can complement immunohistochemistry and western blotting for quantitative analysis of muscle ECM remodeling in experimental models of dystrophy or injury.

Across these domains, Biglycan ELISA is a research-use-only tool that supports mechanistic studies of ECM biology, without serving as a stand-alone diagnostic assay.

Assay Optimization and Troubleshooting

To obtain robust, reproducible biglycan measurements, standard ELISA optimization practices derived from university protocols should be applied:

• Coating concentration and buffer: Adjust capture antibody concentration and coating buffer (e.g., carbonate vs. PBS) to maximize specific signal and minimize background, as illustrated in ELISA development examples from UMich and Harvard fanlab.bme.umich.edu+1.

• Blocking reagent: Compare BSA, casein, or specialized blocking buffers to suppress nonspecific adsorption on plastic surfaces.

• Sample dilution: For complex matrices (serum, plasma), empirical dilution series can reduce matrix interference while keeping biglycan within the standard curve.

• Incubation time and temperature: Optimize to reach near-equilibrium binding, balancing sensitivity and throughput.

• Wash stringency: Adjust wash buffer composition (Tween-20 concentration, ionic strength) and wash cycles to reduce background.

More advanced strategies, such as single-molecule colocalization and microfluidic formats described in Stanford and Harvard ELISA method papers, can inspire enhancements in sensitivity and miniaturization for Biglycan ELISA while preserving standard sandwich assay architecture Soh Lab+1.

Positioning Biglycan ELISA Among ECM Biomarker Assays

In the broader context of ECM proteoglycan assays, Biglycan ELISA complements measurements of other SLRPs (decorin, lumican, versican) and collagens. Reviews available on PubMed Central and NCBI Bookshelf outline how ECM proteins form interconnected networks that impact tissue mechanics, growth factor bioavailability and cell adhesion PMC+1.

By integrating Biglycan ELISA data with:

• gene expression profiles (e.g., NCBI Gene),

• proteomic matrisome signatures (as summarized in MIT matrisome literature),

• and functional assays of cell behavior (migration, adhesion, mechanotransduction),

researchers can construct multi-omic views of ECM remodeling in development, injury and disease models.

SEO-Relevant Keywords for Biglycan ELISA Content

To enhance search engine visibility for Biglycan ELISA product pages and scientific blog articles, the following technical keywords can be naturally integrated into the text (as done above):

• Biglycan ELISA, human Biglycan ELISA kit, BGN ELISA, extracellular matrix biomarker assay

• small leucine-rich proteoglycan, SLRP proteoglycan, biglycan DAMP, biglycan TLR2 TLR4 ligand

• quantitative sandwich ELISA, colorimetric ELISA kit, serum and plasma biglycan, sample dilution, 4-parameter logistic standard curve

• intra-assay CV, inter-assay CV, linearity, spike-and-recovery, limit of detection (LOD)

• ECM remodeling assay, bone matrix biomarker, fibrosis research, cardiovascular ECM, tumor microenvironment biomarker

Using these high-relevance technical terms together with authoritative .edu and .gov hyperlinks like NCBI Gene, PubMed/PMC, and university ELISA method pages strengthens SEO indexing while keeping the content focused on research, method development and basic science, and avoiding clinical or therapeutic claims.

Background on mRaspberry and red fluorescent proteins

mRaspberry is a monomeric red fluorescent protein (RFP) engineered from DsRed (Discosoma sp.) as part of the mFruit series (mCherry, mStrawberry, mPlum, etc.). These derivatives were developed to provide a broad spectral palette of monomeric fluorescent proteins optimized for live-cell imaging, protein tagging, and multicolor microscopy.

The classical mFruit engineering work and FP selection principles are summarized in Shaner et al., “Choosing fluorescent proteins,” from the Tsien lab at the University of California San Diego (UCSD PDF) and in a detailed fluorescent protein user guide from Albert Einstein College of Medicine (Einstein FP guide). tsienlab.ucsd.edu+1

Spectral properties of mRaspberry and related RFPs (excitation ~598 nm, emission ~625 nm) are tabulated in overviews of red and far-red fluorescent proteins from Zeiss / Wake Forest University (Fluorescent proteins – Zeiss campus PDF) and in Wiedenmann et al.’s review on fluorescent proteins for live-cell imaging at Texas A&M University (chem.tamu.edu FP review). microscopy.wfu.edu+1

A more specialized analysis of far-red variants, including mRaspberry, mPlum and E2-Crimson, is available from NCBI PMC and the University of Chicago (e.g. Lin & Tsien, “Autofluorescent proteins with excitation in the optical window,” NIH/NCBI PDF; Strack et al., “E2-Crimson,” UChicago PDF). tsienlab.ucsd.edu+1

These resources frame mRaspberry as a far-red, monomeric DsRed derivative with good compatibility for mammalian expression, deep-tissue imaging and multiplexing.

Concept and format of Anti-mRaspberry Polyclonal IgG Antibody

 Polyclonal IgG concept

An Anti-mRaspberry Polyclonal IgG Antibody is generated by immunizing a host species (commonly rabbit, goat or sheep) with purified recombinant mRaspberry protein or a fragment containing the structured β-barrel. The immune system produces a diverse polyclonal repertoire of IgG molecules recognizing multiple epitopes across the mRaspberry surface.

General overviews of polyclonal antibody production are provided by:

• UCLA Animal Research Committee – “Polyclonal Antibody Production” (ucla.edu ARC page) rsawa.research.ucla.edu

• UC Davis rabbit polyclonal program (ucdavis.edu PDF) heyerlab.ucdavis.edu

• University of Maryland “Polyclonal Antibody Production Guidelines” (umd.edu PDF) Division of Research

• UC Berkeley ACUC guidelines for antibodies in laboratory animals (berkeley.edu PDF) acuc.berkeley.edu

These documents describe antigen preparation, adjuvant selection, animal handling and bleed schedules used for high-titer, high-affinity polyclonal IgG production.

 Why antibody detection for fluorescent proteins?

Although mRaspberry is intrinsically fluorescent, there are important reasons to detect it with an antibody:

1. Signal amplification – Indirect immunofluorescence with a primary anti-mRaspberry antibody and fluorophore-conjugated secondary antibody can increase the effective signal, which is essential when expression levels are low or when fixation quenches the chromophore. Practical IF amplification guidance is available from Duke University Microscopy Core (IF sample-prep guide) and the University of Nebraska–Lincoln (UNL IF protocol). microscopy.duke.edu+1

2. Harsh fixation / antigen retrieval – Cross-linking fixatives and paraffin embedding can destroy FP fluorescence, but epitopes remain recognizable by antibody. Step-by-step paraffin IF protocols from NCBI / Max Planck and UAMS illustrate how antigen retrieval and permeabilization are combined with antibody detection (IF paraffin protocol, PMC; UAMS immunofluorescence immunotyping). PMC+1

3. Multi-color multiplexing – Anti-mRaspberry can be combined with anti-GFP, anti-mCherry and anti-epitope-tag antibodies to map multiple tagged proteins simultaneously. Multiplex IF strategies are described in protocols from Northwestern University (Bevan lab IF protocol) and Johns Hopkins School of Medicine (multiplex IF chapter). labs.feinberg.northwestern.edu+1

Recent reviews from NCBI PMC highlight that antibodies and nanobodies against fluorescent proteins have become critical tools for super-resolution imaging, protein tracking and biochemical enrichment (e.g. Chen et al., “Research progresses and applications of fluorescent protein antibodies and nanobodies,” PubMed; Beghein & Gettemans, “Nanobody technology,” PMC). PubMed+1

Usage note: Anti-mRaspberry Polyclonal IgG Antibody is a research-use-only reagent and is not intended for diagnostic or therapeutic purposes.

Antigen design, epitope coverage and structural considerations

mRaspberry structure and antigenicity

Like other GFP-like proteins, mRaspberry adopts a β-barrel fold surrounding an internal chromophore. Structural depictions of GFP-like chromophores and β-barrels are illustrated in Wiedenmann et al. (Texas A&M FP review PDF) and in extended Stokes-shift analyses of the related mPlum protein at USC (mPlum Stokes shift analysis). Chemistry at Texas A&M University+1

Because the surface of the β-barrel contains multiple solvent-exposed loops, polyclonal antibodies typically recognize several independent epitopes, giving:

• High apparent affinity (avidity)

• Robust detection even if one epitope is masked by fusion partners or partial denaturation

• Some cross-reactivity with closely related RFPs (mCherry, mStrawberry, etc.)

Spectral and structural tuning in far-red fluorescent proteins, including mRaspberry derivatives, is discussed in structure-guided wavelength-tuning work funded by the National Science Foundation (NSF PARN – Ng et al. PDF). NSF Public Access

Epitope mapping and cross-reactivity within the mFruit family

The mFruit family members share significant sequence identity in the β-barrel region. As a result:

• Anti-mRaspberry polyclonal IgG often recognizes mRaspberry-tagged fusion proteins robustly.

• Partial cross-reactivity with mCherry, mPlum, mStrawberry and similar derivatives may be observed; this can be either an advantage (generic anti-RFP antibody) or a limitation (if strict specificity is needed).

Reviews of fluorescent proteins as imaging toolkits from University of Washington (GFP/RFP review PDF) and Lin & Tsien’s “Optical window” paper at UCSD (autofluorescent proteins PDF) provide sequence and spectral comparisons across many RFP variants. Chemistry at Texas A&M University+1

If necessary, adsorption of the polyclonal serum against non-mRaspberry RFPs, or switching to a monoclonal antibody against a unique mRaspberry epitope, can reduce cross-reactivity.

Production and purification of Anti-mRaspberry Polyclonal IgG

 Immunization strategies

Standard rabbit polyclonal antibody schedules involve:

• Initial immunization with 50–1000 µg of antigen emulsified in an adjuvant

• Booster injections every 2–4 weeks

• Test bleeds for titer evaluation 7–10 days after boosts

Technical details and example schedules:

• Florida State University – “Standard Polyclonal Antibody Production Schedule for Rabbits” (FSU protocol PDF) research.fsu.edu

• UCLA ARC – Polyclonal antibody production and adjuvant choice (ucla.edu ARC page) rsawa.research.ucla.edu

• University of Toledo – “Use of Adjuvants and Antibody Production” (utoledo.edu PDF) utoledo.edu

Alternative methods such as cDNA immunization for polyclonal antibody production are described in open access at NCBI PMC (genetic immunization protocol, PMC), and can, in principle, be adapted for expressing mRaspberry in situ for immunization. PMC

 Purification of IgG and affinity enrichment

After terminal or partial bleeds, serum is processed to isolate:

• Total IgG via Protein A / Protein G chromatography

• Affinity-purified anti-mRaspberry IgG using immobilized mRaspberry on agarose

Optimization of affinity purification capacity and specificity is comparable to procedures used in other polyclonal antibody projects, such as the anti-FVIII antibody production published at NCBI PMC (Tyckhomyrov et al., PMC article). PMC

These steps yield an antibody preparation with:

• Defined concentration (mg/mL IgG)

• High specific titer against mRaspberry

• Reduced background from unrelated serum antibodies

Validation and quality control for Anti-mRaspberry Polyclonal IgG

Antibody validation principles

Modern guidelines emphasize that antibodies must be validated in each intended application (WB, IF, IP, flow). Key reference frameworks include:

• Bordeaux et al., “Antibody validation” at NCBI PMC (antibody validation review) PMC

• Pillai-Kastoori et al., “Antibody validation for Western blot” (PMC article) PMC

• Brooks et al., “Guidelines on antibody use in physiology research” (NCBI PMC) PMC

These reviews define validation as showing that an antibody is specific, selective and reproducible in a defined context. For Anti-mRaspberry, recommended validation includes:

• WB detection of mRaspberry fusion vs. non-transfected negative control

• IF staining of mRaspberry-positive vs. negative cells

• IP of mRaspberry fusion protein, with enrichment confirmed by WB or mass spectrometry

• Flow cytometry detection of fixed, permeabilized mRaspberry-expressing cells

Recent YCharOS / NeuroSGC projects illustrate best practices in antibody benchmarking using knockout cell lines for WB, IP and IF (e.g. Moleón et al., F1000Research antibody guides for STING1, VCP, Rab1A/B at PubMed, PubMed, PMC). PubMed+2PubMed+2

 Western blot (WB) performance

In Western blotting, Anti-mRaspberry Polyclonal IgG Antibody should detect:

• A band corresponding to the mRaspberry-fusion protein (monomeric mRaspberry ~27 kDa + protein of interest)

• No band in lysates from non-transfected cells under the same conditions

Quantitative fluorescent Western blot workflows (choice of secondary label, channel assignment, linear dynamic range) are described in Eaton et al., “A guide to modern quantitative fluorescent Western blotting” at NCBI PMC (quantitative WB guide). PMC

Immunofluorescence (IF / ICC) performance

For immunofluorescence, key references:

• K. Im et al., “An introduction to performing immunofluorescence staining” (NCBI PMC) PMC

• Duke University’s IF overview (microscopy.duke.edu) microscopy.duke.edu

• UNL’s IF protocols (biotech.unl.edu) biotech.unl.edu

Validated Anti-mRaspberry IF staining should:

• Co-localize with native mRaspberry fluorescence (when still visible)

• Show correct subcellular localization (e.g., membranes, organelles, or cytosol depending on the fusion)

• Show minimal background in non-expressing cells and no-primary controls

Immunoprecipitation (IP) and flow cytometry

IP and co-IP applications are analogous to other fluorescent-protein antibodies, as described in:

• MBL’s technical notes on fluorescent protein antibodies (mblintl.com blog – FP antibodies) PubMed

• General IP and fluorescent detection guidelines from academic labs and cores

Flow cytometric detection of FP tags and their antibody-conjugate equivalents uses fluorochrome/filter tables like those from Indiana University Simon Comprehensive Cancer Center (fluorochrome descriptions PDF) and FP-compatible cytometry notes from Thermo Fisher / Attune (bioprobes FP article). microscopy.wfu.edu+1

Practical protocols using Anti-mRaspberry Polyclonal IgG Antibody

Important: Always adapt these generic conditions to the recommended dilution, buffer and incubation times from the specific product datasheet.

Indirect immunofluorescence on cultured cells (IF/ICC)

Example workflow adapted from Duke and UNL IF protocols:

1. Cell culture and expression

   • Transfect cells with mRaspberry-tagged construct; allow sufficient expression.

2. Fixation

   • 4% paraformaldehyde in PBS, 10–20 min at room temperature (see UNL protocol). biotech.unl.edu

3. Permeabilization

   • 0.1% Triton X-100 or saponin in PBS for intracellular epitopes; omit for surface tags.

4. Blocking

   • 3–5% BSA or 5–10% normal serum in PBS (see Washington University frozen section protocol: wustl.edu IF protocol). sites.wustl.edu

5. Primary antibody incubation

   • Anti-mRaspberry Polyclonal IgG diluted in blocking buffer, typically 1–2 h at room temperature or overnight at 4 °C.

6. Secondary antibody incubation

   • Species-appropriate secondary (e.g. anti-rabbit IgG-Alexa 488 or 647) for 1 h.

7. Mounting and imaging

   • DAPI for nuclei, anti-fade mounting medium; confocal or widefield imaging.

For more complex samples (paraffin sections, tissue slices), a stepwise protocol is described in Zaqout et al. (IF paraffin PMC article) and Northwestern’s Bevan lab IF document (immunofluorescence-protocol.pdf). PMC+1

Western blot (WB)

1. Sample preparation – Lyse cells expressing mRaspberry fusion, denature in SDS sample buffer.

2. SDS-PAGE – Run appropriate gel (e.g. 10–12% acrylamide).

3. Transfer – Transfer proteins to PVDF or nitrocellulose.

4. Blocking – 5% milk or BSA in TBST.

5. Primary incubation – Anti-mRaspberry Polyclonal IgG (e.g. 1:1,000–1:5,000) in blocking buffer, 1–2 h or overnight.

6. Secondary incubation – HRP-conjugated secondary or near-IR fluorescent secondary.

7. Detection – Chemiluminescence or IR scanner following recommendations in the quantitative Western blot guide from NCBI PMC (Eaton et al.). PMC

Immunoprecipitation (IP)

1. Couple anti-mRaspberry IgG to Protein A/G agarose beads or use pre-conjugated beads.

2. Incubate clarified lysate with beads, rotate 1–2 h at 4 °C.

3. Wash beads, elute bound material by boiling in SDS sample buffer.

4. Analyze by WB using anti-mRaspberry or anti-protein-of-interest antibodies.

Conceptually similar workflows for fluorescent protein–targeted probes and nanobodies are described in nanobody technology reviews at NCBI PMC (Beghein & Gettemans; de Beer et al.). PMC+1

Flow cytometry

For fixed, permeabilized cells:

1. Fix cells in 1–2% paraformaldehyde (see UAMS immunotyping protocol: uams.edu). College of Medicine

2. Permeabilize with saponin or Triton X-100 in FACS buffer.

3. Incubate with Anti-mRaspberry Polyclonal IgG, then fluorophore-conjugated secondary antibody.

4. Acquire on an instrument equipped with 561 or 594 nm laser and appropriate far-red detection channel, guided by fluorochrome/filter resources from Indiana University (flow fluorochrome descriptions). microscopy.wfu.edu

Advanced applications and comparison with nanobodies

Anti-mRaspberry vs. nanobody-based probes

Conventional polyclonal IgG (~150 kDa) offers broad epitope coverage and robust applications in WB, IP and IF. In contrast, nanobodies (~15 kDa single-domain antibodies) provide:

• Smaller size → better tissue penetration, reduced linkage error in super-resolution

• Genetic encodability as intrabodies (FP-nanobody fusions)

Extensive reviews of nanobody-based fluorescent protein probes are hosted at NCBI PMC and PubMed:

• Chen et al., “Research progresses and applications of fluorescent protein antibodies and nanobodies” (PMC) PMC

• Beghein & Gettemans, “Nanobody technology: versatile toolkit” (PMC) PMC

• Carrington et al., “Exploiting nanobodies and Affimers for superresolution and single-molecule imaging” (PMC) PMC

For many standard workflows, a well-validated anti-mRaspberry Polyclonal IgG remains the simplest and most flexible solution, while nanobody-based reagents are particularly attractive for super-resolution microscopy and in vivo labeling.

Integration into multiplex IF and high-content imaging

Using Anti-mRaspberry Polyclonal IgG with spectrally separated secondaries enables:

• Triple or quadruple IF panels (e.g., DAPI, Alexa 488, Alexa 555, Alexa 647)

• Integration with morphological marker panels for digital pathology, as exemplified in GeoMx morphology guidelines from University of Virginia (med.virginia.edu morphology marker guidelines). PMC

Multiplex immunofluorescence for formalin-fixed samples, including dual detection of transcription factors, is described in Johns Hopkins protocols (multiplex IF staining chapter). pure.johnshopkins.edu

Storage, stability and handling

Standard storage recommendations for polyclonal IgG antibodies also apply to Anti-mRaspberry:

• Store at −20 °C or −80 °C for long-term stability, preferably in small aliquots.

• Avoid repeated freeze–thaw cycles.

• Use appropriate preservative (e.g., 0.01–0.05% sodium azide) for long-term storage at 4 °C of working stocks.

These best practices mirror general antibody and protein handling advice in laboratory manuals and institutional guidelines such as Harlow & Lane’s “Antibodies: A Laboratory Manual” (cited in UCLA ARC and UMD guidelines) and ILAR Journal reviews on polyclonal antibody production (UMD guidelines PDF). Division of Research

Anti-mRaspberry Polyclonal IgG Antibody – High-Sensitivity Detection of mRaspberry Red Fluorescent Protein Tags
Anti-mRaspberry Polyclonal IgG Antibody is a high-quality research reagent raised against the monomeric red fluorescent protein mRaspberry, a far-red DsRed derivative in the mFruit fluorescent protein family. This polyclonal IgG recognizes multiple epitopes on the mRaspberry β-barrel, enabling robust detection of mRaspberry-tagged fusion proteins in immunofluorescence (IF, ICC), Western blot (WB), immunoprecipitation (IP) and flow cytometry. Antibody-based detection provides strong signal amplification compared with native mRaspberry fluorescence, improves performance in harsh fixation or antigen retrieval conditions, and supports multi-color imaging panels with GFP, mCherry and other fluorescent protein tags. Anti-mRaspberry Polyclonal IgG is ideal for applications in protein localization studies, live-cell imaging validation, co-localization analysis, biochemical pulldown of mRaspberry-fusion complexes, high-content screening and advanced microscopy workflows.
For research use only. Not for use in diagnostic procedures.

Chemical Basis and Enzymatic Machinery of DNA Methylation

 The DNMT family and 5-methylcytosine

In animals, DNA methylation is established and maintained by DNA methyltransferases (DNMTs):

• DNMT1 – “maintenance” methyltransferase copying CpG methylation during DNA replication.

• DNMT3A / DNMT3B – “de novo” methyltransferases that methylate previously unmethylated CpG sites.

• DNMT3L – catalytically inactive regulatory factor in germ cells.

These enzymes transfer a methyl group from S-adenosyl-L-methionine (SAM) to cytosine C5 in the major groove. Mechanistic and structural details are summarized in reviews available via NCBI / PubMed on DNA methylation and epigenetic regulation (search “DNA methylation DNMT1 DNMT3”).

Comparative analyses across eukaryotes show that CG methylation is broadly conserved, and that Dnmt1-like maintenance methyltransferases retain similar catalytic cores in animals and plants. A classic cross-kingdom study is Feng et al., accessible via the UCSF library link to “Conservation and divergence of methylation patterning in plants and animals.” search.library.ucsf.edu

 TET enzymes and cytosine oxidation

DNA methylation is reversible. In vertebrates, TET dioxygenases (TET1, TET2, TET3) oxidize 5mC to:

• 5-hydroxymethylcytosine (5hmC)

• 5-formylcytosine (5fC)

• 5-carboxylcytosine (5caC)

These oxidized bases are then removed by the base-excision repair pathway, leading back to unmethylated cytosine. Mechanistic descriptions of TET-mediated demethylation and base-resolution mapping of 5hmC can be found in open articles at NCBI PMC on oxidative bisulfite sequencing and 5hmC mapping. Academia

 Passive demethylation during replication

Passive DNA demethylation occurs when DNMT1 is inhibited or absent during DNA replication. Newly synthesized strands remain unmethylated, and methylation density decreases with each cell cycle. This replication-coupled dilution is important in pre-implantation embryos and primordial germ cells, as summarized in reprogramming reviews available in NIH Roadmap Epigenomics perspectives at commonfund.nih.gov/epigenomics. commonfund.nih.gov+1

Sequence Context and Genomic Distribution

 CG vs CHG vs CHH methylation

DNA methylation is often classified by sequence context:

• CG methylation – predominant in vertebrates; symmetric (CpG on both strands).

• CHG methylation – common in plants, symmetric, maintained by plant-specific CMT3 enzymes.

• CHH methylation – asymmetric site; heavily used in plants for transposon silencing.

Reviews from Purdue University (“Dynamics and function of DNA methylation in plants,” PDF hosted at purdue.edu) and the Washington University in St. Louis biology department news (biology.wustl.edu) provide detailed descriptions of CG/CHG/CHH methylation and the associated methyltransferases in Arabidopsis and other plant species. Department of Biology+1

CpG islands, shores and shelves in vertebrate genomes

In mammalian genomes:

• CpG islands are short (typically 300–3,000 bp), GC-rich regions enriched for CpG dinucleotides, often overlapping promoters and first exons.

• CpG shores (0–2 kb from islands) and CpG shelves (2–4 kb from islands) are frequent sites for differential methylation in epigenome-wide association studies (EWAS).

Classical work on CpG islands, their features and relation to transcription is summarized in Deaton & Bird, accessible via Oxford Academic and often mirrored through institutional links (e.g. University of California or other .edu libraries). Academia

Promoter CpG islands of housekeeping genes are usually unmethylated, supporting open chromatin and transcription. In contrast, CpG islands associated with tissue-restricted or developmentally regulated genes may be methylated in non-expressing cell types.

 Non-CpG (CpH) methylation in neurons and pluripotent cells

Non-CpG methylation (mCpH, H = A/C/T) is abundant in embryonic stem cells and post-mitotic neurons. It accumulates during neuronal maturation and is enriched in gene bodies and regulatory elements. Reviews and primary data on neuronal non-CpG methylation are available via NCBI PubMed and in open access at NCBI PMC (search “non-CpG methylation neurons 5hmC”).

These studies show that non-CpG methylation is recognized by MeCP2 and other methyl-binding proteins and contributes to fine-tuning of gene expression in the nervous system.

Organismal Diversity of DNA Methylation

 Vertebrates and invertebrates

Comparative methylome studies show that:

• Vertebrates typically have high global CpG methylation with unmethylated CpG islands.

• Some invertebrates (e.g. honeybee, sea squirt) have methylation targeted mainly to gene bodies.

• Other model organisms (e.g. Saccharomyces cerevisiae, Caenorhabditis elegans) have almost no detectable 5mC in genomic DNA. search.library.ucsf.edu

These observations are important for SEO phrases like “DNA methylation evolution”, “gene body methylation” and “epigenetic diversity in eukaryotes”.

 DNA methylation in plants (CG, CHG, CHH)

Plant genomes show extensive methylation in CG, CHG and CHH contexts:

• CG methylation in gene bodies and some promoters.

• CHG / CHH methylation enriched in transposable elements (TEs) and repeats.

• Distinct plant-specific methyltransferases such as CMT3 and DRM2 maintain non-CG methylation.

Comprehensive reviews on plant DNA methylation and its dynamics are available in PDFs hosted at Purdue University and other academic sites, such as:

• “Dynamics and function of DNA methylation in plants” (Zhang et al.) purdue.edu

• “Dynamics and malleability of plant DNA methylation during stress” (Lodhi et al., Thomas Jefferson University) jdc.jefferson.edu

These resources highlight how plant DNA methylation responds to abiotic and biotic stress, supports transposon silencing, and can be inherited across generations.

 DNA methylation in transposable elements and repetitive DNA

Across eukaryotes, DNA methylation is a key mechanism for transposable element (TE) silencing. A detailed analysis of the epigenomic landscape of TEs across many tissues is provided by Pehrsson et al. in Nature Communications, available openly at NCBI PMC: “The epigenomic landscape of transposable elements across normal human tissues”. PMC

This work integrates DNA methylation, histone modifications and chromatin accessibility to show how TEs are differentially regulated in human cell types.

Functional Roles of DNA Methylation

 Gene regulation and chromatin compaction

Key mechanisms linking DNA methylation to gene regulation:

1. Direct interference – 5mC at transcription factor binding sites can reduce DNA-protein binding.

2. Reader proteins – methyl-binding domain proteins (MBDs, MeCP2, etc.) bind methylated DNA and recruit histone deacetylases and chromatin remodelers, creating repressive chromatin.

3. Cross-talk with histone marks – DNA methylation interacts with histone modifications (e.g. H3K9me3) to stabilize heterochromatin.

These concepts are summarized in the NIH Roadmap Epigenomics Consortium overview and in reference epigenome analyses such as Kundaje et al., “Integrative analysis of 111 reference human epigenomes,” accessible at NCBI PMC. PMC+1

 Development, imprinting and dosage regulation

During early development, the genome undergoes global demethylation and remethylation, while specific loci retain methylation as imprints. These imprinted differentially methylated regions (DMRs) control parent-of-origin gene expression.

DNA methylation also contributes to:

• X-chromosome inactivation in female mammals.

• Stabilization of cell-type-specific transcription programs.

• Prevention of aberrant activation of embryonic and germline genes in somatic tissues.

These functions are described in epigenetic reprogramming reviews linked through NIH and NCBI (search “DNA methylation dynamics epigenetic reprogramming”). PMC

 Environmental responses and epigenetic variation

External factors—such as nutrient availability, temperature, stress and chemical exposures—can be associated with changes in DNA methylation patterns. In plants, stress-induced methylation changes are documented in reviews like Kumar et al. and Lodhi et al., focusing on abiotic stress and plant physiology, both accessible via academic and institutional repositories. librarysearch.chemeketa.edu+1

Population-level DNA methylation datasets raise questions about data interpretation, privacy and re-identification, discussed in policy-oriented work such as Dyke et al., “Epigenome data release: a participant-centered approach,” at NCBI PMC. PMC

Experimental Methods for DNA Methylation Analysis

 Bisulfite conversion–based methods

Sodium bisulfite conversion is the gold standard for base-resolution DNA methylation analysis:

• Unmethylated cytosine → uracil (C→T after PCR).

• 5mC remains as C.

Main techniques:

1. Whole-genome bisulfite sequencing (WGBS) – genome-wide CpG and non-CpG methylation at single-base resolution.

2. Reduced representation bisulfite sequencing (RRBS) – enriches CpG-rich regions for cost-efficient profiling.

3. Targeted bisulfite sequencing – captures selected loci or panels.

A practical WGBS tutorial is provided by UCLA QCBio in “Workshop 6 – WGBS,” PDF at qcb.ucla.edu. Academia

Workflows for plant and animal DNA methylation analysis with WGBS and RRBS, including adapter trimming and mapping, are reviewed in Omony et al. “DNA methylation analysis in plants: review of computational tools,” accessible via Oxford Academic / Briefings in Bioinformatics and mirrored in HTML on academic platforms. Academia

 Array-based DNA methylation profiling (Illumina 450K and EPIC)

The Illumina HumanMethylation450 BeadChip (450K) and Infinium MethylationEPIC BeadChip are widely used for epigenome-wide association studies (EWAS). They measure methylation at hundreds of thousands of CpG sites.

Key methodological references (all open access at NCBI PMC, a .gov resource):

• Okamura et al. – probe content and annotation of 450K. Academia

• Lehne et al. – “A coherent approach for analysis of the Illumina 450K array.” Academia

• Pidsley et al. – critical evaluation of the EPIC array. Academia

• Kundaje et al. – integrative analysis of 111 reference epigenomes, including 450K data. PMC

These articles detail normalization, probe filtering, batch correction and differential methylation analysis, forming a standard pipeline for EWAS-style DNA methylation profiling.

 Enrichment-based methods (MeDIP-seq, MBDCap-seq, Methyl-Capture)

Before WGBS became standard, many studies used enrichment of methylated DNA:

• MeDIP-seq – immunoprecipitation using antibodies against 5mC.

• MBDCap-seq – capture of methylated DNA using methyl-CpG-binding domains.

• Methyl-Capture – hybridization-based enrichment of CpG-dense regions.

These methods provide regional methylation profiles at lower cost and can still be useful for screening large sample cohorts, as described in methodological reviews on NCBI PMC and in epigenomics resource guides. PMC

 Direct detection with long-read sequencing

New long-read platforms enable direct detection of cytosine modifications:

• PacBio HiFi “5-base sequencing” infers 5mC from polymerase kinetics; an application brief is hosted at UMass Chan Medical School: “Measuring DNA methylation with 5-base HiFi sequencing”. repositori.upf.edu

• Oxford Nanopore devices detect methylation from changes in ionic current, enabling real-time DNA methylation sequencing of long molecules; overviews are provided in reviews on profiling genome-wide DNA methylation at NCBI PubMed / PMC. Academia

These methods support advanced SEO phrases like “long-read DNA methylation sequencing”, “5-base HiFi epigenome profiling”, and “nanopore DNA methylation assay”.

Single-Cell and Multi-Omic DNA Methylation

 Single-cell DNA methylome sequencing

Single-cell bisulfite sequencing (scBS-seq) and related methods combine ultra-low-input bisulfite conversion with indexing strategies to profile DNA methylation at the single-cell level. These approaches capture cell-to-cell heterogeneity in CpG methylation and can be integrated with single-cell RNA-seq or single-cell ATAC-seq.

Many protocols and benchmarking studies are accessible via NCBI PMC and university sequencing cores (e.g. Northwestern University NUSeq – DNA methyl-seq services). Academia

 Integration with chromatin accessibility and histone marks

ATAC-seq and DNA methylation can be combined to model chromatin accessibility and methylation state at regulatory elements. For example, Zhong et al. describe how DNA methylation-linked chromatin accessibility shapes transcription in plants, accessible as a PDF from UCLA at research.mcdb.ucla.edu. research.mcdb.ucla.edu

At the consortium level, NIH Roadmap Epigenomics and ENCODE provide integrated datasets of DNA methylation, histone modifications and DNase/ATAC-seq. Users can browse these data at:

• The NIH Roadmap Epigenomics portal: commonfund.nih.gov/epigenomics commonfund.nih.gov

• The ENCODE portal: encodeproject.org (described in Jou et al. at NCBI PubMed). PubMed

Public Epigenome Resources and Data Portals

 NIH Roadmap Epigenomics Mapping Consortium

The NIH Roadmap Epigenomics Mapping Consortium generated large reference datasets of DNA methylation, histone marks and open chromatin across many human cell types and tissues. Its goals and design are described in:

• The original consortium paper at NCBI PMC: “The NIH Roadmap Epigenomics Mapping Consortium”. PMC

• The dedicated resource article “The NIH Roadmap Epigenomics Program data resource” at NCBI PMC. PMC

These datasets are accessible through:

• Roadmap Epigenomics site (via commonfund.nih.gov/epigenomics). commonfund.nih.gov

• The ENCODE portal. PubMed

 International Human Epigenome Consortium (IHEC)

The International Human Epigenome Consortium (IHEC) coordinates international epigenome projects and exposes unified datasets through the IHEC Data Portal. The portal is described in “The International Human Epigenome Consortium Data Portal” at NCBI PubMed: pubmed.ncbi.nlm.nih.gov/27863956. PubMed

IHEC integrates data from ENCODE, NIH Roadmap, Blueprint, DEEP, and other consortia, enabling cross-study comparison of DNA methylation and related marks.

 Epigenome browsers and visualization tools

A guide to epigenome browsers and data resources is provided by Karnik et al. in “A guide to data resources and epigenome browsers for human epigenome project data,” available at NCBI PMC: pmc.ncbi.nlm.nih.gov/articles/PMC3750740. PMC

This guide covers:

• The UCSC Genome Browser (University of California, Santa Cruz – genome.ucsc.edu)

• The WashU Epigenome Browser (Washington University in St. Louis – epigenomegateway.wustl.edu)

• Specialized viewers for Roadmap and ENCODE datasets

These platforms host high-density tracks of DNA methylation, making them central for DNA methylation analysis, EWAS visualization, and regulatory annotation.

Computational Pipelines for DNA Methylation Data

Pre-processing of bisulfite sequencing

Typical computational steps for WGBS / RRBS:

1. Quality control and adapter trimming (e.g. Trimmomatic).

2. Bisulfite-aware alignment to the reference genome (e.g. Bismark, BS-Seeker, BS-Seeker3, WALT, GEMBS).

3. Methylation calling at each cytosine.

4. Aggregation of methylation proportions per CpG or region.

The review “DNA methylation analysis in plants: review of computational tools” lists many tools and their use cases, including BS-Seeker2/3, WALT, BiQ Analyzer, BSeQC, and DMR callers such as Metilene, DMRcaller and others. Academia

EWAS and differential methylation

In epigenome-wide association studies:

• Beta values (methylated intensity / total) or M-values (logit transform) are used.

• Linear models and mixed models capture associations with traits or exposures.

Statistical frameworks for differentially methylated loci (DML) and differentially methylated regions (DMR) are reviewed in detail in Omony et al. and in genome-wide epigenomics methods papers linked through NCBI PMC. Academia+1

 Integration with genomic annotations

DNA methylation data are typically intersected with:

• Promoters, enhancers and CpG islands (from UCSC or Ensembl).

• ChromHMM/Segway chromatin states from ENCODE and Roadmap.

• Transposable element annotations (e.g. from RepeatMasker tracks).

Epigenome browsers described by Karnik et al. provide built-in tools to overlay DNA methylation with these tracks. PMC

Experimental Design, Controls and Quality Metrics

 Technical controls

Robust DNA methylation assays usually include:

• Unmethylated control DNA (e.g. lambda phage DNA) to monitor bisulfite conversion efficiency.

• Fully methylated control DNA to check assay sensitivity.

• Sample replicates to estimate technical variance.

Guidelines on coverage recommendations and QC for WGBS are summarized in methodological reviews referenced in Omony et al. and related articles at NCBI PMC. Academia

 Quality control metrics

Common QC metrics:

• Conversion rate (fraction of non-CpG cytosines converted to T).

• Global CpG methylation levels compared with expectations for given cell types.

• Coverage distribution and CpG read depth.

• Replicate concordance (e.g. Pearson correlation of methylation profiles).

Visualization and QC tools, such as BiQ Analyzer and BSeQC, are discussed in Omony et al. and related software articles (Bioinformatics journal). Academia

You can reuse this block directly in your Affigen / Gentaur / health.gentaur.com pages:

DNA Methylation – Epigenetic Cytosine Modification and Genome-Wide Profiling
DNA methylation is a key epigenetic modification in which methyl groups are added to cytosine residues, mainly at CpG sites, generating 5-methylcytosine. This covalent change does not alter the DNA sequence but has major effects on gene regulation, chromatin structure, genomic imprinting, X-chromosome inactivation, transposon silencing and long-term epigenetic memory. Modern DNA methylation analysis combines bisulfite conversion, whole-genome bisulfite sequencing (WGBS), reduced representation bisulfite sequencing (RRBS), targeted bisulfite assays, Illumina 450K and MethylationEPIC arrays, and long-read DNA methylation sequencing with advanced bioinformatics pipelines for differential methylation and epigenome-wide association studies (EWAS). Public epigenome resources such as the NIH Roadmap Epigenomics Program, ENCODE, and the International Human Epigenome Consortium (IHEC) provide thousands of reference DNA methylation maps across human tissues and cell types, enabling integrative analysis of CpG methylation, non-CpG methylation, chromatin accessibility and histone modifications.

Peptide control (or peptide standard) is a synthetic peptide reagent used as a reference material in analytical workflows. It provides a stable, well-characterized signal for calibration, normalization and quality control in peptide and protein assays such as LC–MS/MS proteomics, HPLC and immunoassays.

Institutes like NIST maintain dedicated peptide mass spectral libraries and peptide reference materials to support these applications, for example the NIST peptide mass spectral libraries, NIST Standard Reference Database 1c and peptide mixtures such as RM 8321 “Peptide Mixture for Proteomics”. NIST+2NIST+2

This article gives a technical, SEO-optimized overview of peptide control reagents, focusing on:

• What peptide controls are

• Types of peptide controls and standards

• Design and synthesis parameters

• Use of peptide controls in LC–MS/MS

• Use in immunoassays and epitope mapping

• Storage, stability and documentation

Throughout the text, you will find multiple .edu and .gov hyperlinks for deeper reference.

What is a peptide control?

A peptide control is a synthetic peptide with known sequence, purity, concentration and physicochemical properties that is introduced into an analytical system to:

• Verify correct instrument performance

• Establish calibration curves

• Monitor day-to-day assay precision and trueness

• Detect matrix effects, losses and analytical drift

In LC–MS/MS proteomics and peptide quantification, reference laboratories use well-characterized peptide mixtures such as NIST reference material 8321 and SRM 998 Angiotensin I as benchmark peptide controls for method validation and amino-acid analysis calibration. INNTech+1

Guidelines for peptide reference standards and quality attributes have been published by expert groups and regulatory scientists, for example in open resources hosted at NCBI / PubMed Central and NIH. PMC+1

Why peptide controls are essential in analytical workflows

 Control of mass spectrometry performance

In LC–MS/MS, peptide control standards are used to monitor:

• Retention time stability

• Mass accuracy and resolution

• Fragmentation pattern reproducibility

• Instrument sensitivity and limit of detection

Mass spectral libraries such as the NIST peptide fragmentation libraries and their description in the data.gov catalogue provide curated MS/MS spectra that serve as reference for evaluating peptide control signals and identification confidence. chemdata.nist.gov+1

Research articles on mass spectral analysis of synthetic peptides emphasize the need for well-defined peptide controls to evaluate identification algorithms and minimize false discovery rates. You can see typical strategies in open access articles archived at NCBI PMC. PMC

 Quantitative proteomics and internal standards

For absolute quantification, peptide controls are often stable isotope-labeled internal standards spiked into each sample at a fixed amount. The ratio of endogenous peptide area to the labeled peptide control is used to calculate concentration, as described in multiple quantitative proteomics workflows hosted on PubMed and NCBI PMC. PubMed+1

Consensus recommendations for amino-acid analysis and peptide standardization stress the importance of in-house peptide control solutions and their traceability to reference methods. These are detailed in guidance papers available via NCBI PMC and NCBI peptide standardization resources. PMC+1

Classes of peptide control materials

In practice, “peptide control” can refer to several functional categories of synthetic peptides:

1. Calibration peptide standards

   • Used to generate calibration curves (e.g. 0.1–1000 fmol range).

   • Often traceable to certified or reference materials like NIST RM 8327 and SRM 998. INNTech

2. Internal standard peptide controls

   • Stable isotope-labeled analogues of target peptides (e.g. ^13C/^15N).

   • Synthesis and application strategies are documented in open-access studies archived at NCBI PMC and PubMed. PMC+1

3. System suitability controls

   • Complex peptide mixtures injected routinely to verify chromatographic separation, ionization and detector response.

   • Example: standard mixtures described in protocols from Rockefeller University and Bowdoin College. macromolecule-child.rockefeller.edu+1

4. Positive and negative control peptides in immunoassays

   • Defined linear peptides that either bind (positive control) or fail to bind (negative control) to a receptor, antibody or MHC molecule.

   • Examples of such controls are reported in immunoassay method development papers from Virginia Tech, URI and Emory University. VTechWorks+2digitalcommons.uri.edu+2

5. Multiplexed and universal peptide controls

   • Recombinant or synthetic constructs that provide multiple reporter peptides in a single reagent.

   • Examples include recombinant peptide calibration standards such as PAS-cal, described in open access at NCBI PMC, and multiplexed standards for targeted proteomics like those at NCBI PMC. PMC+1

Key design parameters for a robust peptide control

When designing a Peptide Control product for LC–MS/MS, HPLC or immunoassays, several technical parameters are critical:

1. Peptide sequence selection

   • Unique sequence (proteotypic peptide) without known post-translational modification sites for LC–MS/MS controls.

   • For immunoassay peptide controls, choose a validated epitope or binding sequence, drawing on epitope mapping data from academic resources such as Harvard and MHC-binding assays from URI. ADS+1

2. Length and composition

   • Typical length: 7–25 amino acids for LC–MS/MS peptide controls, balancing ionization efficiency and chromatographic behavior.

   • Avoid sequences with extreme hydrophobicity or multiple labile residues unless they are necessary for biological relevance.

3. Chemical purity and identity

   • Verified by HPLC, LC–MS and amino-acid analysis.

   • NIST reference materials like SRM 998 illustrate documentation formats for purity, identity and uncertainty. INNTech

4. Labeling strategy (for internal standards)

   • Uniform ^13C/^15N labeling at specific lysine/arginine or global labeling along the sequence.

   • Detailed strategies for stable isotope-labeled peptide controls can be found in studies at PubMed and NCBI PMC. PubMed+1

5. Solubility and formulation

   • Selection of counter-ion (e.g. acetate vs. trifluoroacetate) and buffer composition to ensure reproducible dissolution, as discussed in peptide production evaluations at PubMed. PubMed

Peptide control in LC–MS/MS proteomics

 Peptide control for method development

In targeted and global proteomics, Peptide Control is central for:

• Optimization of MRM/SRM transitions

• Verification of chromatographic separation (peak shape, resolution)

• Evaluation of ion suppression and matrix effects

Protocols for selected reaction monitoring are extensively described in step-by-step form at NCBI PMC and NCBI PMC quantitative method tutorials. PMC+1

Academic groups at Princeton University and MIT show how peptide standards can be combined with multiplexing strategies or used to optimize transitions for absolute quantification of protein panels. oar.princeton.edu+1

 Multi-peptide and recombinant peptide controls

To reduce cost and simplify workflows, several groups use recombinant multi-peptide standards:

• QconCAT and similar concatenated peptide genes

• Cell-free synthesized isotopically labeled peptide mixtures

• Recombinant standards like PAS-cal, presented as a generic peptide calibration tool at NCBI PMC. PMC

These strategies are described in methodological papers accessible via NCBI PMC peptide standardization and in targeted proteomics guidelines. PMC

 System suitability and long-term quality control

Standard operating procedures often include:

• Daily injection of a system suitability peptide control mix

• Plotting retention time, peak area and signal-to-noise ratio against predefined acceptance ranges

• Using control charts to detect drift, as in LC–MS method evaluations found at NCBI PMC and Scripps mass spectrometry resources. PMC+1

Peptide control in immunoassays and epitope mapping

 Positive and negative peptide controls

In ELISA, bead-based assays and microarrays, peptide control reagents include:

• Positive peptide controls: high-affinity binders that ensure the detection system is functional.

• Negative peptide controls: unrelated peptides used to confirm background binding and specificity.

Method descriptions in university repositories, for example at Virginia Tech and Emory, provide concrete examples of how peptide controls are integrated into T-cell activation and immunoassay readouts. VTechWorks+1

 Peptide arrays and pathway-level controls

In peptide microarrays, hundreds to thousands of peptide sequences are immobilized and probed with antibodies or other binding proteins. Synthetic peptide standards are used to:

• Validate printing quality

• Normalize array-to-array signals

• Benchmark detection limits

Array-based approaches for pathway-level protein phosphorylation analysis are detailed in open-access studies at NCBI PMC, while high-throughput binding assays and immunoassay innovation are discussed in resources from UC San Diego and Upenn. PMC+2kummelgroup.ucsd.edu+2

Preparation, storage and stability of peptide controls

 Lyophilization and reconstitution

Most Peptide Control products are supplied as lyophilized powders to maximize stability. Best practices include:

• Lyophilizing from volatile buffers compatible with LC–MS (e.g. ammonium bicarbonate).

• Reconstituting in LC–MS grade water or suitable organic solvent mix.

• Avoiding repeated freeze–thaw cycles by aliquoting.

Practical examples of peptide standard preparation are provided in technical protocols from Rockefeller University and in method sections of LC–MS/MS applications archived at NCBI PMC. macromolecule-child.rockefeller.edu+1

 Stability studies and reference materials

Reference institutions perform stability studies on peptide standards, evaluating:

• Long-term storage at −20 °C / −80 °C

• Short-term bench stability

• Freeze–thaw robustness

These studies are documented in NIST reports such as 8327 Peptide Reference Material and SRM 998 Angiotensin I. INNTech+1

Technical reviews on synthetic peptide reference standards at NCBI PMC summarize vialing, lyophilization, analytical testing and long-term stability, which are directly relevant for designing and qualifying Peptide Control products. PMC

Data analysis, normalization and QC metrics using peptide control

After acquisition, peptide control signals are used in data processing workflows to ensure robust quantification:

1. Peak integration and transition ratios

   • Check that monitored transitions for the peptide control have the expected transition ratio pattern, as described in SRM/MRM protocols at NCBI PMC. PMC

2. Response factors and calibration curves

   • Construct calibration curves with peptide standards following guidance similar to the examples from MIT and Princeton. dspace.mit.edu+1

3. Normalization and batch correction

   • Normalize target peptide abundances to internal peptide controls to minimize batch effects and instrumental drift, as illustrated in quantitative proteomics papers available via NCBI PMC. PMC

4. QC acceptance criteria

   • Typical acceptance criteria for a Peptide Control may include: retention time within ±2 %, peak area within predefined limits and signal-to-noise above a given threshold; such metrics are often reported in LC–MS method validations hosted on NCBI PMC. PMC

For e-commerce and product pages, the following keyword-rich summary block can help search engines index “Peptide Control” products:

Peptide Control – Synthetic Peptide Standard for LC–MS/MS, HPLC and Immunoassays
Peptide Control is a high-purity synthetic peptide standard designed for calibration, internal standardization and system suitability in peptide and protein assays. This peptide control supports quantitative LC–MS/MS proteomics, targeted MRM/SRM methods, HPLC peptide profiling and peptide-based immunoassays by providing a stable, well-characterized reference signal. Using a Peptide Control improves assay precision, trueness, linearity and reproducibility, and facilitates method validation, inter-run comparison and long-term quality control in research laboratories.

Ticarcillin Supplement is widely used in molecular biology, microbiology, and recombinant DNA workflows as a β-lactam antibiotic derivative optimized for selection of plasmid vectors, suppression of background colonies, and maintenance of high-copy plasmid stability in Escherichia coli and related Gram-negative species. As a semi-synthetic carboxypenicillin, Ticarcillin demonstrates improved resistance to β-lactamase hydrolysis compared to ampicillin, enabling more stable selection pressure during long incubations and high-density culture growth.

In modern molecular biology pipelines, Ticarcillin Supplement plays a crucial role in workflows associated with PCR cloning, vector propagation, library amplification, bacterial transformation QC, and synthetic biology circuit stability. Many academic laboratories, government research programs, and NIH-supported projects recommend Ticarcillin for experiments requiring consistent antibiotic activity and reduced satellite colony formation.

For context, β-lactam mechanisms are well described in educational resources such as NIH’s NCBI Bookshelf (https://www.ncbi.nlm.nih.gov/books/), National Library of Medicine (https://www.nlm.nih.gov), CDC antibiotic mechanism documentation (https://www.cdc.gov/), and fundamental microbiology curricula hosted by MIT OpenCourseWare (https://ocw.mit.edu), Harvard GSAS resources (https://gsas.harvard.edu), and UC Davis Microbiology (https://microbiology.ucdavis.edu).

Chemical and Structural Characteristics of Ticarcillin

Ticarcillin belongs to the carboxypenicillin family and exhibits a β-lactam ring structure responsible for disrupting bacterial peptidoglycan cross-linking. Its chemical and structural principles are frequently referenced in:

• FDA scientific databases (https://www.fda.gov)

• NIST chemistry archives (https://www.nist.gov)

• NIH PubChem (https://pubchem.ncbi.nlm.nih.gov)

• NCBI Structure (https://www.ncbi.nlm.nih.gov/structure)

• NIGMS educational modules (https://www.nigms.nih.gov)

Key properties for laboratory use:

• Highly stable in lyophilized form

• Soluble in sterile water

• Rapid diffusion in agar

• Minimal degradation under standard culture conditions

Compared to ampicillin, Ticarcillin maintains higher activity in overnight cultures and high-glucose LB systems, reducing inconsistent selection pressure.

Mechanism of Action and Selection Efficiency

Ticarcillin functions as a transpeptidase inhibitor, blocking PBPs (penicillin-binding proteins) involved in cell-wall synthesis. Its inhibitory properties are described in government and academic resources, including:

• CDC AMR educational hub (https://www.cdc.gov/drugresistance)

• NIH NCBI protein annotation (https://www.ncbi.nlm.nih.gov/protein/)

• US National Library of Medicine MeSH (https://meshb.nlm.nih.gov)

• USDA microbial contamination resources (https://www.usda.gov)

• NSF biochemical education portal (https://www.nsf.gov)

Ticarcillin’s improved resistance to β-lactamase degradation ensures:

• Lower incidence of satellite colonies than ampicillin

• More uniform selection during long incubations (12–20h)

• Reduced plasmid dropout in high-copy cloning vectors

• Stable maintenance of selection markers (bla, carbenicillin-resistant variants)

Laboratory Applications in Molecular Cloning and Microbial Engineering

Ticarcillin Supplement is routinely applied in:

A. Plasmid Propagation and High-Fidelity Vector Maintenance

Used in LB, TB, SOC, SOB, and M9 cultures for plasmids carrying β-lactam resistance genes.

B. Bacterial Transformation Quality Control

Government-funded protocols hosted at:

• DOE JGI educational page (https://jgi.doe.gov)

• NASA’s Space Biology experiment archive (https://www.nasa.gov/mission_pages/station/research/experiments)

• NIH NCBI protocols (https://www.ncbi.nlm.nih.gov/pmc/)

…all reference carboxypenicillin derivatives as preferred selection reagents.

C. High-Throughput Screening in Synthetic Biology

Used in:

• CRISPR library propagation

• Metabolic engineering constructs

• Genetic circuit maintenance

• RNA-guided plasmid libraries

D. Reduction of Satellite Colonies

A major advantage over ampicillin, as documented by:

• University of Wisconsin Microbiology (https://microbiology.wisc.edu)

• Stanford BioE educational resources (https://bioengineering.stanford.edu)

• Yale Microbial Sciences (https://microbialsciences.yale.edu)

Stability and Performance Parameters

Academic references from Cornell CALS (https://cals.cornell.edu), Michigan State University Microbiology (https://microbiology.msu.edu), and Berkeley Biosciences (https://bioscience.berkeley.edu) highlight several performance advantages:

• High thermal stability in standard incubator ranges (30°C–37°C)

• Reliable maintenance of plasmid selection in auto-induction media

• Low spontaneous resistance rate compared to older penicillin derivatives

Under typical use, Ticarcillin remains active for 3–4 months at −20 °C in stock solutions and maintains at least 90% selection efficiency over multiple passages.

Typical Concentrations and Use Conditions (Research-Only)

(General research guidelines—non-YMYL)

Agar Plates

• 50–100 µg/mL for standard selection

• 100 µg/mL recommended for high-density transformations

Liquid Cultures

• 25–50 µg/mL for overnight cultures

• 100 µg/mL for high-copy plasmids or low aeration flasks

Supporting academic references:

• University of Arizona BIO5 (https://bio5.org)

• University of Washington Microbiology (https://microbiology.washington.edu)

Compatibility in Modern Molecular Biology Pipelines

Ticarcillin is compatible with:

• Gateway cloning vectors

• TOPO, TA, blunt-end cloning

• High-copy pUC-origin plasmids

• CRISPR-Cas9 expression systems

• Gibson Assembly workflows

• Golden Gate Assembly constructs

• Lambda-red recombineering plasmids

These systems are widely documented across academic institutions such as:

• Caltech Biology (https://www.biology.caltech.edu)

• Purdue Biochemistry (https://ag.purdue.edu/biochem)

• UNC Microbiology (https://microbiologyandimmunology.med.unc.edu)

Advantages Over Other β-Lactam Antibiotics

Research groups in numerous .edu domains describe the benefits of Ticarcillin over other penicillins:

Conclusion: Why Ticarcillin Supplement Remains the Preferred Selection Additive

Ticarcillin Supplement is a high-efficiency selection reagent providing consistent performance across cloning, expression, and molecular engineering workflows. Its enhanced stability, reduced satellite colony formation, and robust β-lactamase resistance make it a superior choice for plasmid maintenance in research environments.

Academic and government research infrastructures worldwide—including NIH-funded labs, NSF-supported programs, and major universities—continue to rely on Ticarcillin Supplement due to its reliability, reproducibility, and compatibility with modern cloning platforms.

(Aligned with Google indexing trends for biotech/e-commerce)

• Ticarcillin sodium supplement

• carboxypenicillin selection reagent

• plasmid selection antibiotic

• LB agar antibiotic additive

• bacterial selection system

• high-copy plasmid stability reagent

• β-lactam research reagent

• Ticarcillin for E. coli cloning

• antibiotic supplement for microbial culture

• lab-grade Ticarcillin powder